t(3;9;22) 3-Way Chromosome Translocation in Chronic Myeloid Leukemia is Associated with Poor Prognosis

Autor: Suneeta Primanneni, Jiahuai Tan, Karen Seiter, Shundong Cang, Delong Liu, Nasir Ahmed, Thomas Mathews
Rok vydání: 2009
Předmět:
Male
Cancer Research
Chromosomes
Human
Pair 22

Dasatinib
Chromosome 9
Chromosomal translocation
Biology
Philadelphia chromosome
Dexamethasone
Piperazines
Translocation
Genetic

Antibodies
Monoclonal
Murine-Derived

Fatal Outcome
hemic and lymphatic diseases
Antineoplastic Combined Chemotherapy Protocols
medicine
Humans
Philadelphia Chromosome
Cyclophosphamide
Protein Kinase Inhibitors
neoplasms
Genetics
Antibodies
Monoclonal

Myeloid leukemia
Karyotype
General Medicine
Middle Aged
Prognosis
medicine.disease
Thiazoles
Methotrexate
Pyrimidines
Imatinib mesylate
Oncology
Chromosome 3
Doxorubicin
Drug Resistance
Neoplasm

Vincristine
Karyotyping
Benzamides
Leukemia
Myeloid
Chronic-Phase

Disease Progression
Imatinib Mesylate
Cancer research
Chromosomes
Human
Pair 3

Blast Crisis
Chromosomes
Human
Pair 9

Rituximab
Chronic myelogenous leukemia
Zdroj: Cancer Investigation. 27:718-722
ISSN: 1532-4192
0735-7907
DOI: 10.1080/07357900802653498
Popis: Chronic myelogenous leukemia (CML) is genetically characterized by the reciprocal translocation of chromosome 9 and 22. Around 5-8% of CML develop complex variant Ph translocations involving one or more chromosomal regions besides 9 and 22. Chromosome 3 is not frequently involved in complex translocations in CML. We report in this study a case of CML displaying a t(3;9;22) 3-way translocation. A review of the literature appears to indicate that CML patients with this translocation tend to have an aggressive course and poor outcome. Additional 3-way chromosome translocations associated with CML are also reviewed.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje